Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Bioxytran's total debt was $48.07K at Jun 30, 2025. For fiscal 2024 it was $48.00K, up 92.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $48.00K | +92.0% |
| FY2017 | Dec 31, 2017 | $25.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | $48.07K | +92.3% |
| Q1 FY2025 | Mar 31, 2025 | $48.00K | +92.0% |
| Q4 FY2024 | Dec 31, 2024 | $48.00K | +92.0% |
| Q1 FY2021 | Mar 31, 2021 | $420.75K | – |
| Q2 FY2018 | Jun 30, 2018 | $25.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $25.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $25.00K | – |
See a number that looks wrong?